FIRRM and endometrial cancer: Furthermore, expression levels of C1ORF112 are correlated with survival in endometrial cancer, and patients with higher levels of expression of the gene also have a poorer prognosis (https://www.proteinatlas.org/ENSG00000000460‐C1orf112/pathology).